Judge Won't Toss Teva's Migraine Drug IP Suit Against Eli Lilly

By Jasmin Boyce (March 15, 2022, 7:49 PM EDT) -- A Massachusetts federal judge refused on Tuesday to boot Teva Pharmaceutical's patent suit against rival Eli Lilly over a competing migraine medication, ruling that Eli Lilly was relying on claim construction arguments that were inappropriate at this early stage of the case....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!